Best Programmed Death Ligand-1 Blocker for carcinoma, transitional cell
Top-rated pick: Bavencio — pharmaranks score 70/100, the highest of the 2 Programmed Death Ligand-1 Blocker drugs used for carcinoma, transitional cell, ranked by our independent FDA recall-safety score. Compare them with all treatments for carcinoma, transitional cell or the full Programmed Death Ligand-1 Blocker class. Not medical advice — always consult a professional.
Quick answer: Of the 2 programmed death ligand-1 blocker drugs we rate for carcinoma, transitional cell, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for carcinoma, transitional cell; the right choice depends on your situation, so confirm it with your prescriber.
Top programmed death ligand-1 blocker for carcinoma, transitional cell: 1. Bavencio · 2. Imfinzi
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Injectable | — | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | — | — | View → |
Full ranking · 2 drugs
bavencio
PrescriptionFDA-sourced
Bavencio (Avelumab) is a programmed death ligand-1 blocker used to treat Transitional Cell Carcinoma, Merkel Cell Carcinoma.
Price varies
imfinzi
PrescriptionFDA-sourced
Imfinzi (Durvalumab) is a programmed death ligand-1 blocker used to treat Transitional Cell Carcinoma.
Price varies
Frequently asked
- What is the best programmed death ligand-1 blocker for carcinoma, transitional cell?
- By our independent recall-safety rating — not an efficacy measure — bavencio ranks highest among Programmed Death Ligand-1 Blocker drugs used for carcinoma, transitional cell. Always consult a professional.
- Which programmed death ligand-1 blocker drugs treat carcinoma, transitional cell?
- pharmaranks lists 2 Programmed Death Ligand-1 Blocker products used for carcinoma, transitional cell, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.